TRAUMA TO THE DEVELOPING BRAIN--RESPONSE AND TREATMENT

发育中大脑的创伤——应对和治疗

基本信息

  • 批准号:
    2892375
  • 负责人:
  • 金额:
    $ 14.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-07-10 至 2003-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Applicant's Abstract): Traumatic brain injury is the most common cause of death and acquired disability in childhood in the United States. It has long been recognized in the clinical realm that infants and young children exhibit brain injury syndromes which are unique to this age group and are associated with particularly high morbidity and mortality. Because the brain changes dramatically during early development with respect to its mechanical properties, regional metabolism, myelination, vascular supply, neurotransmitter activity, and gene expression, its response to trauma is likely to differ significantly from that seen in adults. Therapies based on the response of the mature brain to injury therefore may be ineffective or even counterproductive in the immature nervous system. The few studies of brain injury in immaturity to date have relied primarily on rodent models, which differ in major morphologic and developmental characteristics from humans. Because of the morphometric and developmental similarities between the piglet and human brain we have developed a focal contusion model which is scaled for use in piglets at ages corresponding to human infants, toddlers, and adolescents. Use of this model will allow for the determination of age-specific differences in the histologic and pathophysiologic response of the brain to this common form of pediatric brain injury, and we hypothesize that vulnerability will be greatest in the youngest ages. These differences also will be visible in vivo using magnetic resonance imaging and spectroscopy in piglets after sealed focal injury, using the latest techniques for characterizing injury response in children. Similar age- dependent vulnerability of the immature brain to damage after trauma will correlate with a) physiologic instability after injury. Finally, because of these interrelated developmental changes including susceptibility to excitotoxic insult, we hypothesize that the neuroprotective efficacy of NMDA receptor antagonists will vary significantly with age. This important information will be useful in the development and testing of head injury therapies appropriate for infants and children.
描述:(申请人的摘要):创伤性脑损伤是指 儿童死亡和后天残疾的最常见原因 美国的 在临床领域中,长期以来一直认识到, 婴儿和幼儿表现出脑损伤综合征, 这是这个年龄组所特有的, 发病率和死亡率。因为大脑会发生巨大的变化 机械性能方面的早期发展,区域 代谢,髓鞘形成,血管供应,神经递质活性,和 基因表达,其对创伤的反应可能不同, 与成年人相比有显著差异。基于反应的治疗 因此,成熟大脑的损伤可能是无效的,甚至 在未成熟的神经系统中起反作用少数研究 迄今为止,未成年人的脑损伤主要依赖于啮齿动物 模型,其在主要形态和发育方面不同 人类的特征。 由于形态学和 我们发现的小猪和人类大脑的发育相似性 开发了一个局部挫伤模型,该模型按比例用于仔猪, 年龄相当于人类婴儿、幼儿和青少年。 使用 该模型将允许确定特定年龄的差异, 大脑对此的组织学和病理生理学反应 常见的小儿脑损伤,我们假设, 在最年轻的年龄段,脆弱性将最大。 这些差异 也将在体内使用磁共振成像可见, 光谱学在仔猪密封局灶性损伤后,使用最新的 描述儿童损伤反应的技术。 年龄相仿- 创伤后未成熟大脑对损伤的依赖性脆弱性 将与a)损伤后的生理不稳定性相关。 最后, 由于这些相互关联的发展变化, 易受兴奋性毒性损伤,我们假设, NMDA受体拮抗剂的神经保护功效将变化 随着年龄的显著。 这一重要信息将有助于 开发和测试适用于以下情况的头部损伤治疗方法: 婴儿和儿童。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ann-Christine Duhaime其他文献

Ann-Christine Duhaime的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ann-Christine Duhaime', 18)}}的其他基金

PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
环孢菌素 A 治疗儿童 TBI 的临床前试验
  • 批准号:
    8514740
  • 财政年份:
    2011
  • 资助金额:
    $ 14.22万
  • 项目类别:
PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
环孢菌素 A 治疗儿童 TBI 的临床前试验
  • 批准号:
    8535509
  • 财政年份:
    2011
  • 资助金额:
    $ 14.22万
  • 项目类别:
PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
环孢菌素 A 治疗儿童 TBI 的临床前试验
  • 批准号:
    8286175
  • 财政年份:
    2011
  • 资助金额:
    $ 14.22万
  • 项目类别:
PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
环孢菌素 A 治疗儿童 TBI 的临床前试验
  • 批准号:
    8042851
  • 财政年份:
    2011
  • 资助金额:
    $ 14.22万
  • 项目类别:
Trauma to Immature Brain: Response Repair & Treatment
未成熟大脑的创伤:反应修复
  • 批准号:
    7394402
  • 财政年份:
    2004
  • 资助金额:
    $ 14.22万
  • 项目类别:
Trauma to Immature Brain: Response Repair & Treatment
未成熟大脑的创伤:反应修复
  • 批准号:
    7215529
  • 财政年份:
    2004
  • 资助金额:
    $ 14.22万
  • 项目类别:
Trauma to Immature Brain: Response Repair & Treatment
未成熟大脑的创伤:反应修复
  • 批准号:
    6826017
  • 财政年份:
    2004
  • 资助金额:
    $ 14.22万
  • 项目类别:
Trauma to Immature Brain: Response Repair & Treatment
未成熟大脑的创伤:反应修复
  • 批准号:
    6904683
  • 财政年份:
    2004
  • 资助金额:
    $ 14.22万
  • 项目类别:
Trauma to Immature Brain: Response Repair & Treatment
未成熟大脑的创伤:反应修复
  • 批准号:
    7037673
  • 财政年份:
    2004
  • 资助金额:
    $ 14.22万
  • 项目类别:
TRAUMA TO THE DEVELOPING BRAIN--RESPONSE AND TREATMENT
发育中大脑的创伤——应对和治疗
  • 批准号:
    6393891
  • 财政年份:
    1998
  • 资助金额:
    $ 14.22万
  • 项目类别:

相似海外基金

Nonlocal Variational Problems from Physical and Biological Models
物理和生物模型的非局部变分问题
  • 批准号:
    2306962
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Standard Grant
Point-of-care optical spectroscopy platform and novel ratio-metric algorithms for rapid and systematic functional characterization of biological models in vivo
即时光学光谱平台和新颖的比率度量算法,可快速、系统地表征体内生物模型的功能
  • 批准号:
    10655174
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2022
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Discovery Grants Program - Individual
Micro-electrofluidic platforms for monitoring 3D human biological models
用于监测 3D 人体生物模型的微电流体平台
  • 批准号:
    DP220102872
  • 财政年份:
    2022
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Discovery Projects
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2021
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Discovery Grants Program - Individual
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2020
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Discovery Grants Program - Individual
Harnessing machine learning and cloud computing to test biological models of the role of white matter in human learning
利用机器学习和云计算来测试白质在人类学习中的作用的生物模型
  • 批准号:
    2004877
  • 财政年份:
    2020
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Fellowship Award
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
便携式低成本调查点 CapCell 示波器,用于对体外和体内生物模型中的主要代谢轴和相关脉管系统进行成像和量化
  • 批准号:
    9899988
  • 财政年份:
    2019
  • 资助金额:
    $ 14.22万
  • 项目类别:
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2019
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Discovery Grants Program - Individual
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
便携式低成本调查点 CapCell 示波器,用于对体外和体内生物模型中的主要代谢轴和相关脉管系统进行成像和量化
  • 批准号:
    9753458
  • 财政年份:
    2019
  • 资助金额:
    $ 14.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了